British journal of Cancer |
The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer |
aoû. 18 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term outcomes of patients with 10 or more colorectal liver metastases |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer |
mai. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study |
aoû. 16 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study |
avr. 19 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study |
aoû. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study |
avr. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer |
Jan. 17 |
2 ♥ |
Cancer colorectal |
British journal of Cancer |
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study. |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228) |
sep. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial |
avr. 19 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
British journal of Cancer |
The impact of age on complications, survival, and cause of death following colon cancer surgery |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab |
juin. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab |
oct. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours |
sep. 17 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response. |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest |
juin. 15 |
2 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer |
nov. 15 |
2 ♥ |
Cancer colorectal (CCR) |